Sign up for the premium plan and unlock all options
After purchasing the premium plan, you will unlock all information about drug prices and their availability.
Search
Listing 25441 - 25460 out of 485193 entries
| Country | ATC | Drug name | Drug form, strength, package | Price level | Price in € | Price in local currency | Therapeutic areas | Manufacturer / Importer |
|---|---|---|---|---|---|---|---|---|
| Australia | (L04AA06) mycophenolic acid | Mycophenolate (Apo) 250 mg capsule, 100 | Capsule containing mycophenolate mofetil 250 mg, 100 pcs | Retail price without vat |
$0-0 |
$0-0 |
n/a | ApotexPtyLtd |
| Australia | (L04AA06) mycophenolic acid | Mycophenolate (Pharmacor) 250 mg capsule, 100 | Capsule containing mycophenolate mofetil 250 mg, 100 pcs | Retail price without vat |
$0-0 |
$0-0 |
n/a | PharmacorPtyLimited |
| Australia | (L04AA06) mycophenolic acid | Mycophenolate (Pharmacor) 250 mg capsule, 100 | Capsule containing mycophenolate mofetil 250 mg, 100 pcs | Retail price without vat |
$0-0 |
$0-0 |
n/a | PharmacorPtyLimited |
| Australia | (L04AA06) mycophenolic acid | Mycophenolate (Pharmacor) 250 mg capsule, 100 | Capsule containing mycophenolate mofetil 250 mg, 100 pcs | Retail price without vat |
$0-0 |
$0-0 |
n/a | PharmacorPtyLimited |
| Australia | (L04AA06) mycophenolic acid | Mycophenolate (Sandoz) 250 mg capsule, 100 | Capsule containing mycophenolate mofetil 250 mg, 100 pcs | Retail price without vat |
$0-0 |
$0-0 |
n/a | SandozPtyLtd |
| Australia | (L04AA06) mycophenolic acid | Mycophenolate (Sandoz) 250 mg capsule, 100 | Capsule containing mycophenolate mofetil 250 mg, 100 pcs | Retail price without vat |
$0-0 |
$0-0 |
n/a | SandozPtyLtd |
| Australia | (L04AA06) mycophenolic acid | Mycophenolate (Sandoz) 250 mg capsule, 100 | Capsule containing mycophenolate mofetil 250 mg, 100 pcs | Retail price without vat |
$0-0 |
$0-0 |
n/a | SandozPtyLtd |
| Australia | (N04BD03) safinamide (adm: O) | Xadago 100 mg tablet, 30 | Tablet 100 mg, 30 pcs | Retail price without vat |
$0-0 |
$0-0 |
Parkinson Disease | ClinectPtyLtd |
| Australia | (N04BD03) safinamide (adm: O) | Xadago 100 mg tablet, 30 | Tablet 100 mg, 30 pcs | Retail price without vat |
$0-0 |
$0-0 |
Parkinson Disease | ClinectPtyLtd |
| Australia | (N04BD03) safinamide (adm: O) | Xadago 50 mg tablet, 30 | Tablet 50 mg, 30 pcs | Retail price without vat |
$0-0 |
$0-0 |
Parkinson Disease | ClinectPtyLtd |
| Australia | (N04BD03) safinamide (adm: O) | Xadago 50 mg tablet, 30 | Tablet 50 mg, 30 pcs | Retail price without vat |
$0-0 |
$0-0 |
Parkinson Disease | ClinectPtyLtd |
| Australia | (N05AX08) risperidone | Risvan (1 x 100 mg syringe, 1 x 0.49 mL inert diluent syringe), 1 pack | I.M. injection (modified release), set containing 1 pre-filled syringe powder for injection 100 mg and 1 pre-filled syringe diluent 490 microlitres, 1 pcs | Retail price without vat |
$0-0 |
$0-0 |
n/a | ServierLaboratories(Aust.)Pty.Ltd. |
| Australia | (N05AX08) risperidone | Risvan (1 x 75 mg syringe, 1 x 0.383 mL inert diluent syringe), 1 pack | I.M. injection (modified release), set containing 1 pre-filled syringe powder for injection 75 mg and 1 pre-filled syringe diluent 383 microlitres, 1 pcs | Retail price without vat |
$0-0 |
$0-0 |
n/a | ServierLaboratories(Aust.)Pty.Ltd. |
| Australia | (N06AA10) nortriptyline | Allegron 10 mg tablet, 50 | Tablet 10 mg (as hydrochloride), 50 pcs | Retail price without vat |
$0-0 |
$0-0 |
n/a | ArrowPharmaPtyLtd |
| Australia | (N06AA10) nortriptyline | Allegron 25 mg tablet, 50 | Tablet 25 mg (as hydrochloride), 50 pcs | Retail price without vat |
$0-0 |
$0-0 |
n/a | ArrowPharmaPtyLtd |
| Australia | (S01LA05) aflibercept | Eylea 2 mg/0.05 mL injection, 0.05 mL syringe | Solution for intravitreal injection 3.6 mg in 90 microlitres (40 mg per mL) pre-filled syringe, 1 pcs | Retail price without vat |
$0-0 |
$0-0 |
Wet Macular Degeneration;Macular Edema;Diabetes Complications;Retinal Vein Occlusion;Choroidal Neovascularization | BayerAustraliaLtd |
| Australia | (S01LA05) aflibercept | Eylea 2 mg/0.05 mL injection, 0.05 mL syringe | Solution for intravitreal injection 3.6 mg in 90 microlitres (40 mg per mL) pre-filled syringe, 1 pcs | Retail price without vat |
$0-0 |
$0-0 |
Wet Macular Degeneration;Macular Edema;Diabetes Complications;Retinal Vein Occlusion;Choroidal Neovascularization | BayerAustraliaLtd |
| Australia | (S01LA05) aflibercept | Eylea 2 mg/0.05 mL injection, 0.05 mL syringe | Solution for intravitreal injection 3.6 mg in 90 microlitres (40 mg per mL) pre-filled syringe, 1 pcs | Retail price without vat |
$0-0 |
$0-0 |
Wet Macular Degeneration;Macular Edema;Diabetes Complications;Retinal Vein Occlusion;Choroidal Neovascularization | BayerAustraliaLtd |
| Australia | (S01LA05) aflibercept | Eylea 2 mg/0.05 mL injection, 0.05 mL syringe | Solution for intravitreal injection 3.6 mg in 90 microlitres (40 mg per mL) pre-filled syringe, 1 pcs | Retail price without vat |
$0-0 |
$0-0 |
Wet Macular Degeneration;Macular Edema;Diabetes Complications;Retinal Vein Occlusion;Choroidal Neovascularization | BayerAustraliaLtd |
| Australia | (S01LA05) aflibercept | Eylea 2 mg/0.05 mL injection, 0.05 mL syringe | Solution for intravitreal injection 3.6 mg in 90 microlitres (40 mg per mL) pre-filled syringe, 1 pcs | Retail price without vat |
$0-0 |
$0-0 |
Wet Macular Degeneration;Macular Edema;Diabetes Complications;Retinal Vein Occlusion;Choroidal Neovascularization | BayerAustraliaLtd |
Pages
